| 14.5 |
58.0 |
GO:0046552 |
eye photoreceptor cell fate commitment(GO:0042706) photoreceptor cell fate commitment(GO:0046552) |
| 10.4 |
41.5 |
GO:0014846 |
esophagus smooth muscle contraction(GO:0014846) |
| 8.5 |
68.0 |
GO:0048625 |
myoblast fate commitment(GO:0048625) |
| 5.5 |
16.4 |
GO:0021529 |
spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
| 5.3 |
26.6 |
GO:0015671 |
oxygen transport(GO:0015671) |
| 4.9 |
24.7 |
GO:0072015 |
ciliary body morphogenesis(GO:0061073) glomerular visceral epithelial cell development(GO:0072015) glomerular epithelial cell development(GO:0072310) |
| 3.9 |
7.8 |
GO:0021913 |
regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
| 3.9 |
19.5 |
GO:2000325 |
regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
| 3.1 |
9.2 |
GO:1903225 |
negative regulation of endodermal cell differentiation(GO:1903225) |
| 3.1 |
15.4 |
GO:0097475 |
motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
| 3.0 |
9.1 |
GO:0006597 |
spermine biosynthetic process(GO:0006597) |
| 2.6 |
21.0 |
GO:0021546 |
rhombomere development(GO:0021546) |
| 2.3 |
11.6 |
GO:0035262 |
gonad morphogenesis(GO:0035262) |
| 2.3 |
6.8 |
GO:0042320 |
regulation of circadian sleep/wake cycle, REM sleep(GO:0042320) circadian sleep/wake cycle, REM sleep(GO:0042747) positive regulation of circadian sleep/wake cycle, sleep(GO:0045938) |
| 2.1 |
27.9 |
GO:0042573 |
retinoic acid metabolic process(GO:0042573) |
| 2.1 |
8.4 |
GO:1903966 |
monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
| 2.0 |
6.1 |
GO:0090425 |
hepatocyte cell migration(GO:0002194) branching involved in pancreas morphogenesis(GO:0061114) acinar cell differentiation(GO:0090425) positive regulation of forebrain neuron differentiation(GO:2000979) |
| 2.0 |
18.2 |
GO:0048664 |
neuron fate determination(GO:0048664) |
| 1.9 |
7.7 |
GO:0045091 |
regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045091) |
| 1.8 |
18.3 |
GO:0051574 |
positive regulation of histone H3-K9 methylation(GO:0051574) |
| 1.6 |
9.8 |
GO:0007253 |
cytoplasmic sequestering of NF-kappaB(GO:0007253) |
| 1.6 |
4.7 |
GO:0003345 |
proepicardium cell migration involved in pericardium morphogenesis(GO:0003345) |
| 1.5 |
12.3 |
GO:0014816 |
skeletal muscle satellite cell differentiation(GO:0014816) |
| 1.5 |
3.0 |
GO:0008582 |
regulation of synaptic growth at neuromuscular junction(GO:0008582) |
| 1.5 |
13.5 |
GO:1902166 |
negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902166) |
| 1.4 |
5.8 |
GO:1903898 |
positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
| 1.3 |
6.4 |
GO:0070934 |
CRD-mediated mRNA stabilization(GO:0070934) |
| 1.2 |
8.2 |
GO:0007296 |
vitellogenesis(GO:0007296) |
| 1.2 |
5.8 |
GO:0015705 |
iodide transport(GO:0015705) |
| 1.1 |
3.4 |
GO:0030210 |
heparin biosynthetic process(GO:0030210) Tie signaling pathway(GO:0048014) |
| 1.1 |
2.1 |
GO:0010908 |
regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition(GO:0044334) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
| 1.0 |
10.4 |
GO:2001214 |
positive regulation of vasculogenesis(GO:2001214) |
| 1.0 |
2.9 |
GO:0014826 |
vein smooth muscle contraction(GO:0014826) |
| 1.0 |
8.6 |
GO:0031642 |
negative regulation of myelination(GO:0031642) negative regulation of receptor catabolic process(GO:2000645) |
| 0.9 |
6.4 |
GO:0006703 |
estrogen biosynthetic process(GO:0006703) |
| 0.9 |
4.5 |
GO:0060040 |
retinal bipolar neuron differentiation(GO:0060040) |
| 0.9 |
12.6 |
GO:0060736 |
prostate gland growth(GO:0060736) |
| 0.9 |
4.4 |
GO:0035426 |
extracellular matrix-cell signaling(GO:0035426) |
| 0.9 |
3.5 |
GO:0021780 |
oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
| 0.8 |
7.6 |
GO:0090166 |
Golgi disassembly(GO:0090166) |
| 0.8 |
5.6 |
GO:1900029 |
positive regulation of ruffle assembly(GO:1900029) |
| 0.8 |
3.2 |
GO:0035878 |
nail development(GO:0035878) |
| 0.8 |
3.9 |
GO:1900147 |
Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
| 0.8 |
3.9 |
GO:0071699 |
olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
| 0.7 |
3.7 |
GO:0006177 |
GMP biosynthetic process(GO:0006177) |
| 0.7 |
1.5 |
GO:1903026 |
negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
| 0.7 |
2.9 |
GO:0046533 |
regulation of photoreceptor cell differentiation(GO:0046532) negative regulation of photoreceptor cell differentiation(GO:0046533) astrocyte activation(GO:0048143) |
| 0.7 |
2.1 |
GO:0035989 |
tendon development(GO:0035989) |
| 0.7 |
2.1 |
GO:0046101 |
hypoxanthine metabolic process(GO:0046100) hypoxanthine biosynthetic process(GO:0046101) |
| 0.7 |
2.0 |
GO:0014005 |
microglia differentiation(GO:0014004) microglia development(GO:0014005) |
| 0.7 |
4.6 |
GO:0034638 |
phosphatidylcholine catabolic process(GO:0034638) |
| 0.6 |
1.3 |
GO:1900220 |
semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
| 0.6 |
2.9 |
GO:0033087 |
negative regulation of immature T cell proliferation(GO:0033087) |
| 0.6 |
4.0 |
GO:0043569 |
negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
| 0.6 |
6.8 |
GO:0048672 |
positive regulation of collateral sprouting(GO:0048672) |
| 0.6 |
1.7 |
GO:0035928 |
mitochondrial RNA 3'-end processing(GO:0000965) RNA 5'-end processing(GO:0000966) rRNA import into mitochondrion(GO:0035928) |
| 0.5 |
6.4 |
GO:0019985 |
translesion synthesis(GO:0019985) |
| 0.5 |
4.2 |
GO:0097152 |
mesenchymal cell apoptotic process(GO:0097152) regulation of mesenchymal cell apoptotic process(GO:2001053) negative regulation of mesenchymal cell apoptotic process(GO:2001054) |
| 0.5 |
7.8 |
GO:0048387 |
negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
| 0.5 |
1.0 |
GO:0072103 |
glomerulus vasculature morphogenesis(GO:0072103) glomerular capillary formation(GO:0072104) |
| 0.5 |
3.6 |
GO:0046477 |
glycosylceramide catabolic process(GO:0046477) |
| 0.5 |
2.0 |
GO:0007113 |
endomitotic cell cycle(GO:0007113) |
| 0.5 |
1.5 |
GO:0060399 |
positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
| 0.4 |
1.3 |
GO:0016445 |
somatic diversification of immunoglobulins(GO:0016445) |
| 0.4 |
1.3 |
GO:0007181 |
transforming growth factor beta receptor complex assembly(GO:0007181) negative regulation of apoptotic process involved in morphogenesis(GO:1902338) negative regulation of apoptotic process involved in development(GO:1904746) |
| 0.4 |
4.8 |
GO:0097034 |
mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
| 0.4 |
1.3 |
GO:1901896 |
positive regulation of calcium-transporting ATPase activity(GO:1901896) |
| 0.4 |
5.2 |
GO:0002043 |
blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
| 0.4 |
4.2 |
GO:0032876 |
negative regulation of DNA endoreduplication(GO:0032876) |
| 0.4 |
7.1 |
GO:0031987 |
locomotion involved in locomotory behavior(GO:0031987) |
| 0.4 |
4.6 |
GO:0006610 |
ribosomal protein import into nucleus(GO:0006610) |
| 0.4 |
4.1 |
GO:0090557 |
establishment of endothelial intestinal barrier(GO:0090557) |
| 0.4 |
0.8 |
GO:0002314 |
germinal center B cell differentiation(GO:0002314) |
| 0.4 |
1.9 |
GO:0021631 |
optic nerve morphogenesis(GO:0021631) |
| 0.4 |
3.8 |
GO:0021796 |
cerebral cortex regionalization(GO:0021796) |
| 0.3 |
2.8 |
GO:0050957 |
equilibrioception(GO:0050957) |
| 0.3 |
4.7 |
GO:0038063 |
collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
| 0.3 |
4.6 |
GO:0015937 |
coenzyme A biosynthetic process(GO:0015937) |
| 0.3 |
2.9 |
GO:2001224 |
positive regulation of neuron migration(GO:2001224) |
| 0.3 |
2.6 |
GO:0032625 |
interleukin-21 production(GO:0032625) interleukin-21 secretion(GO:0072619) |
| 0.3 |
4.8 |
GO:0051382 |
kinetochore assembly(GO:0051382) |
| 0.3 |
6.3 |
GO:0060009 |
Sertoli cell development(GO:0060009) |
| 0.3 |
7.1 |
GO:0006825 |
copper ion transport(GO:0006825) |
| 0.3 |
0.9 |
GO:0060023 |
soft palate development(GO:0060023) |
| 0.3 |
3.3 |
GO:1902459 |
positive regulation of stem cell population maintenance(GO:1902459) |
| 0.3 |
0.9 |
GO:0001547 |
antral ovarian follicle growth(GO:0001547) |
| 0.3 |
0.6 |
GO:0060596 |
mammary placode formation(GO:0060596) |
| 0.3 |
1.4 |
GO:0006348 |
chromatin silencing at telomere(GO:0006348) |
| 0.3 |
1.4 |
GO:0072488 |
ammonium transmembrane transport(GO:0072488) |
| 0.3 |
10.9 |
GO:0010718 |
positive regulation of epithelial to mesenchymal transition(GO:0010718) |
| 0.3 |
5.4 |
GO:0034142 |
toll-like receptor 4 signaling pathway(GO:0034142) |
| 0.3 |
0.5 |
GO:0035701 |
hematopoietic stem cell migration(GO:0035701) |
| 0.3 |
8.7 |
GO:0010972 |
negative regulation of G2/M transition of mitotic cell cycle(GO:0010972) |
| 0.3 |
0.5 |
GO:1901860 |
positive regulation of mitochondrial DNA metabolic process(GO:1901860) |
| 0.2 |
1.0 |
GO:0006529 |
asparagine biosynthetic process(GO:0006529) |
| 0.2 |
5.1 |
GO:1901522 |
positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus(GO:1901522) |
| 0.2 |
2.7 |
GO:0071578 |
zinc II ion transmembrane import(GO:0071578) |
| 0.2 |
14.5 |
GO:0051384 |
response to glucocorticoid(GO:0051384) |
| 0.2 |
2.4 |
GO:0061032 |
visceral serous pericardium development(GO:0061032) |
| 0.2 |
1.6 |
GO:0048251 |
elastic fiber assembly(GO:0048251) |
| 0.2 |
2.3 |
GO:0097531 |
mast cell migration(GO:0097531) |
| 0.2 |
1.9 |
GO:0043518 |
negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
| 0.2 |
2.7 |
GO:0003214 |
cardiac left ventricle morphogenesis(GO:0003214) |
| 0.2 |
2.1 |
GO:0019511 |
peptidyl-proline hydroxylation(GO:0019511) |
| 0.2 |
2.1 |
GO:0045723 |
positive regulation of fatty acid biosynthetic process(GO:0045723) |
| 0.2 |
4.6 |
GO:0001706 |
endoderm formation(GO:0001706) |
| 0.2 |
0.8 |
GO:0070537 |
histone H2A K63-linked deubiquitination(GO:0070537) |
| 0.2 |
11.6 |
GO:0042475 |
odontogenesis of dentin-containing tooth(GO:0042475) |
| 0.2 |
4.9 |
GO:0045747 |
positive regulation of Notch signaling pathway(GO:0045747) |
| 0.2 |
1.9 |
GO:0009404 |
toxin metabolic process(GO:0009404) |
| 0.2 |
3.2 |
GO:0016339 |
calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
| 0.2 |
21.1 |
GO:0006261 |
DNA-dependent DNA replication(GO:0006261) |
| 0.2 |
1.8 |
GO:0042541 |
hemoglobin biosynthetic process(GO:0042541) |
| 0.2 |
1.7 |
GO:0045040 |
protein import into mitochondrial outer membrane(GO:0045040) |
| 0.2 |
1.9 |
GO:0033572 |
transferrin transport(GO:0033572) |
| 0.2 |
0.5 |
GO:0045358 |
negative regulation of interferon-beta biosynthetic process(GO:0045358) |
| 0.2 |
0.9 |
GO:0006957 |
complement activation, alternative pathway(GO:0006957) |
| 0.1 |
0.9 |
GO:0005513 |
detection of calcium ion(GO:0005513) |
| 0.1 |
0.5 |
GO:1903031 |
regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
| 0.1 |
0.5 |
GO:0001826 |
inner cell mass cell differentiation(GO:0001826) |
| 0.1 |
6.2 |
GO:1901998 |
toxin transport(GO:1901998) |
| 0.1 |
1.6 |
GO:0009048 |
dosage compensation by inactivation of X chromosome(GO:0009048) |
| 0.1 |
0.4 |
GO:0006556 |
S-adenosylmethionine biosynthetic process(GO:0006556) |
| 0.1 |
0.8 |
GO:0060613 |
fat pad development(GO:0060613) |
| 0.1 |
5.1 |
GO:0006493 |
protein O-linked glycosylation(GO:0006493) |
| 0.1 |
3.0 |
GO:0095500 |
acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
| 0.1 |
4.5 |
GO:0021680 |
cerebellar Purkinje cell layer development(GO:0021680) |
| 0.1 |
2.6 |
GO:0034724 |
DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
| 0.1 |
3.4 |
GO:0006730 |
one-carbon metabolic process(GO:0006730) |
| 0.1 |
10.7 |
GO:0048015 |
phosphatidylinositol-mediated signaling(GO:0048015) |
| 0.1 |
0.7 |
GO:0070102 |
interleukin-6-mediated signaling pathway(GO:0070102) |
| 0.1 |
1.6 |
GO:0045722 |
positive regulation of gluconeogenesis(GO:0045722) |
| 0.1 |
0.8 |
GO:0007250 |
activation of NF-kappaB-inducing kinase activity(GO:0007250) |
| 0.1 |
1.6 |
GO:0033194 |
response to hydroperoxide(GO:0033194) |
| 0.1 |
2.3 |
GO:0006303 |
double-strand break repair via nonhomologous end joining(GO:0006303) |
| 0.1 |
6.8 |
GO:0070374 |
positive regulation of ERK1 and ERK2 cascade(GO:0070374) |
| 0.1 |
0.6 |
GO:0000395 |
mRNA 5'-splice site recognition(GO:0000395) |
| 0.1 |
0.3 |
GO:0060690 |
epithelial cell differentiation involved in salivary gland development(GO:0060690) |
| 0.1 |
2.2 |
GO:0007099 |
centriole replication(GO:0007099) |
| 0.1 |
2.5 |
GO:0000462 |
maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
| 0.1 |
4.8 |
GO:0050728 |
negative regulation of inflammatory response(GO:0050728) |
| 0.1 |
4.9 |
GO:0051225 |
spindle assembly(GO:0051225) |
| 0.1 |
3.1 |
GO:1902653 |
cholesterol biosynthetic process(GO:0006695) secondary alcohol biosynthetic process(GO:1902653) |
| 0.1 |
1.4 |
GO:0048599 |
oocyte development(GO:0048599) |
| 0.1 |
1.7 |
GO:0048791 |
calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
| 0.1 |
2.5 |
GO:0032088 |
negative regulation of NF-kappaB transcription factor activity(GO:0032088) |
| 0.1 |
0.5 |
GO:0048730 |
epidermis morphogenesis(GO:0048730) |
| 0.0 |
3.8 |
GO:0046034 |
ATP metabolic process(GO:0046034) |
| 0.0 |
0.3 |
GO:0043552 |
positive regulation of phosphatidylinositol 3-kinase activity(GO:0043552) |
| 0.0 |
2.6 |
GO:0007156 |
homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
| 0.0 |
0.7 |
GO:0070167 |
regulation of bone mineralization(GO:0030500) regulation of biomineral tissue development(GO:0070167) |
| 0.0 |
0.6 |
GO:0006744 |
ubiquinone metabolic process(GO:0006743) ubiquinone biosynthetic process(GO:0006744) |
| 0.0 |
2.5 |
GO:0043627 |
response to estrogen(GO:0043627) |
| 0.0 |
0.9 |
GO:0006625 |
protein targeting to peroxisome(GO:0006625) peroxisomal transport(GO:0043574) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
| 0.0 |
4.0 |
GO:0000910 |
cytokinesis(GO:0000910) |
| 0.0 |
0.6 |
GO:0051457 |
maintenance of protein location in nucleus(GO:0051457) |
| 0.0 |
1.3 |
GO:0042773 |
ATP synthesis coupled electron transport(GO:0042773) |
| 0.0 |
0.6 |
GO:0032291 |
central nervous system myelination(GO:0022010) axon ensheathment in central nervous system(GO:0032291) |
| 0.0 |
1.0 |
GO:0001947 |
heart looping(GO:0001947) |
| 0.0 |
2.7 |
GO:0007030 |
Golgi organization(GO:0007030) |
| 0.0 |
0.6 |
GO:0001967 |
suckling behavior(GO:0001967) |
| 0.0 |
0.5 |
GO:0045214 |
sarcomere organization(GO:0045214) |
| 0.0 |
0.4 |
GO:1902043 |
positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
| 0.0 |
0.5 |
GO:0001522 |
pseudouridine synthesis(GO:0001522) |
| 0.0 |
3.0 |
GO:0098780 |
mitophagy in response to mitochondrial depolarization(GO:0098779) response to mitochondrial depolarisation(GO:0098780) |
| 0.0 |
0.2 |
GO:0007220 |
Notch receptor processing(GO:0007220) |
| 0.0 |
1.0 |
GO:0009060 |
aerobic respiration(GO:0009060) |
| 0.0 |
0.7 |
GO:0051865 |
protein autoubiquitination(GO:0051865) |
| 0.0 |
0.3 |
GO:0043968 |
histone H2A acetylation(GO:0043968) |
| 0.0 |
1.3 |
GO:0048593 |
camera-type eye morphogenesis(GO:0048593) |
| 0.0 |
1.6 |
GO:0001666 |
response to hypoxia(GO:0001666) |
| 0.0 |
0.9 |
GO:1903955 |
positive regulation of protein targeting to mitochondrion(GO:1903955) |
| 0.0 |
1.2 |
GO:0016579 |
protein deubiquitination(GO:0016579) |
| 0.0 |
1.3 |
GO:0043123 |
positive regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043123) |
| 0.0 |
0.5 |
GO:0010507 |
negative regulation of autophagy(GO:0010507) |
| 0.0 |
2.9 |
GO:0007067 |
mitotic nuclear division(GO:0007067) |
| 0.0 |
1.0 |
GO:0007283 |
spermatogenesis(GO:0007283) male gamete generation(GO:0048232) |
| 0.0 |
0.2 |
GO:0044342 |
type B pancreatic cell proliferation(GO:0044342) |
| 0.0 |
2.5 |
GO:0043161 |
proteasome-mediated ubiquitin-dependent protein catabolic process(GO:0043161) |
| 0.0 |
0.9 |
GO:0016197 |
endosomal transport(GO:0016197) |
